<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04940377</url>
  </required_header>
  <id_info>
    <org_study_id>60861</org_study_id>
    <nct_id>NCT04940377</nct_id>
  </id_info>
  <brief_title>Effect of the Genotype on Postoperative DVT</brief_title>
  <official_title>Postoperative Venous Thromboembolism Risk in 140,831 Surgical Patients - a Genetic Association Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Postoperative Venous Thromboembolism Events (VTE) constitute a major source of morbidity and&#xD;
      mortality after surgery. The aim of this study was to investigate whether commonly occurring&#xD;
      Single Nucleotide Polymorphisms (SNPs) are associated with VTE in the surgical setting.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Data extracted from the participants in the UK Biobank collaborative study. Two cohorts will&#xD;
      be examined:&#xD;
&#xD;
        1. Surgical cohort, consisting of all patients with a registered surgical procedure in the&#xD;
           UK biobank repository&#xD;
&#xD;
        2. Validation cohort, consisting of all non-surgical patients in the UK biobank repository.&#xD;
&#xD;
      A GWAS approach will be used to associated commonly occurring single nucleotide polymorphisms&#xD;
      (SNPs) with a postoperative venous thromboembolic event (VTE) within 30 days of a surgical&#xD;
      procedure in the surgical cohort.&#xD;
&#xD;
      Findings from the surgical GWAS step will be replicated in the Validation cohort in order to&#xD;
      assess whether the same SNPs drive both surgical and non-surgical VTE risk.&#xD;
&#xD;
      A final GWAS model will be fielded, correction for confounders including sex, age, smoking,&#xD;
      obesity and open/minimal invasive surgery (surgical discovery GWAS only).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 1, 2020</start_date>
  <completion_date type="Actual">June 1, 2021</completion_date>
  <primary_completion_date type="Actual">March 1, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <target_duration>10 Years</target_duration>
  <primary_outcome>
    <measure>Postoperative VTE event</measure>
    <time_frame>30 days of a surgical procedure</time_frame>
  </primary_outcome>
  <enrollment type="Actual">502505</enrollment>
  <condition>Venous Thromboembolism</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy volunteers followed by the UK biobank consortium&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        - All patients included in the UK biobank repository&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
        - None&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 17, 2021</study_first_submitted>
  <study_first_submitted_qc>June 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 25, 2021</study_first_posted>
  <last_update_submitted>June 25, 2021</last_update_submitted>
  <last_update_submitted_qc>June 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Martin Sillesen</investigator_full_name>
    <investigator_title>Assoc. Prof.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thromboembolism</mesh_term>
    <mesh_term>Venous Thromboembolism</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

